Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Oseltamivir

An influenza antiviral approved in 1999: it inhibits neuraminidase, the enzyme the virus uses to leave infected cells. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?Its synthesis was built on shikimic acid, at first available only as an extract of Chinese star anise; by 2006 about 30% was already made by genetically modified Escherichia coli bacteria.

OseltamivirGo to the active ingredient →
OseltamivirActive ingredientOseltamivirCat. No. P-O039-001CAS 196618-13-0
Oseltamivir-d3Isotopically labelledOseltamivir-d3Cat. No. P-O039-016CAS 1093851-61-6

EDQM standards 5

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.